In this issue

 The evolution of rectal cancer treatment: the journey to total neoadjuvant therapy and organ preservation

Arthur Affleck, Marina Affi Koprowski, Nima Nabavizadeh, Vassiliki Liana Tsikitis

 

 

 

PDF HTML

 Frailty in metabolic syndrome, focusing on nonalcoholic fatty liver disease

Nikolaos D. Karakousis, Lampros Chrysavgis, Antonios Chatzigeorgiou, George Papatheodoridis, Evagelos Cholongitas

 

 

 

PDF HTML

 Comprehensive National Inpatient Sample data reveals low but rising Pneumocystis jiroveci pneumonia risk in inflammatory bowel disease patients

Jeffrey Schwartz, Daniel J. Stein, Joseph D. Feuerstein

 

 

PDFHTML

 Effect of obesity on vedolizumab response in inflammatory bowel disease

Louis J. Levine, Jill K. J. Gaidos, Deborah D. Proctor, Artur V. Viana, Badr Al Bawardy

 

 

PDF HTML


 

Current Issue

Volume 35, No 3 (2022)

Published: 2022-05-12

Table of contents

Review Articles

Current views

Original Articles

View All Issues